Clinical Trial Update: Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports on the efficacy and safety of donepezil (Aricept) in patients with severe Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Aricept (Donepezil)

Snippet

Sponsor: Eisai Inc. | Conditions: Alzheimer's Disease, Dementia | Phase 3 | Status: COMPLETED